Biogen Pharmachem Industries Completes Allotment of 15,04,33,833 Bonus Equity Shares

Biogen Pharmachem Industries Limited has completed the allotment of bonus equity shares, with the process finalised on 18.05.2026. The allotment was carried out under Regulation 30, underscoring the company's adherence to regulatory disclosure norms governing corporate actions.

Bonus Share Allotment Details

The company has issued a substantial number of bonus equity shares to its shareholders as part of this corporate action. The key details of the allotment are summarised below:

Parameter: Details Type of Shares: Bonus Equity Shares Number of Shares Allotted: 15,04,33,833 Regulatory Framework: Regulation 30 Date of Completion: 18.05.2026

Regulatory Compliance

The allotment of 15,04,33,833 bonus equity shares was completed in compliance with Regulation 30, which mandates timely disclosure of material corporate events to stock exchanges. Biogen Pharmachem Industries Limited fulfilled its disclosure obligations by reporting the completion of this bonus share allotment as required under the applicable regulatory framework.

Biogen Pharmachem Industries Limited, formerly known as Sun Techno Overseas Limited, released its audited standalone financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results at its meeting held on May 14, 2026. The statutory auditors, M/s. Goenka Mehta & Associates, Chartered Accountants, issued an unmodified opinion on the financial results.

Full-Year Financial Performance

For the year ended March 31, 2026, Biogen Pharmachem recorded a notable turnaround, posting a net profit of ₹85.95 lacs against a net loss of ₹29.27 lacs in the year ended March 31, 2025. Revenue from operations rose sharply to ₹255.80 lacs from ₹83.84 lacs in the prior year, entirely driven by other operating revenue, as gross revenue from sale of products remained nil in both periods. Total expenses for FY26 stood at ₹160.13 lacs compared to ₹113.11 lacs in FY25, with employee benefit expenses increasing to ₹28.28 lacs from ₹16.79 lacs and other expenses rising to ₹131.85 lacs from ₹96.32 lacs. Tax expense of ₹9.73 lacs was recorded in FY26, with no tax expense in the prior year.

The following table summarises the key annual financial metrics (Rs. in lacs):

Metric: FY26 (Audited) FY25 (Audited) Revenue from Operations: 255.80 83.84 Total Income: 255.80 83.84 Employee Benefit Expense: 28.28 16.79 Other Expenses: 131.85 96.32 Total Expenses: 160.13 113.11 Profit/(Loss) Before Tax: 95.67 (29.27) Tax Expense: 9.73 - Net Profit/(Loss) After Tax: 85.95 (29.27) Total Comprehensive Income: 85.95 (29.27) Basic EPS (₹1/- each, not annualised): 0.01 (0.00) Diluted EPS (₹1/- each, not annualised): 0.01 (0.00)

Quarterly Financial Highlights

For the quarter ended March 31, 2026, the company reported a loss before tax of ₹35.88 lacs, compared to a profit of ₹117.78 lacs in the quarter ended March 31, 2025. Revenue from operations for Q4 FY26 stood at ₹57.82 lacs, down from ₹135.23 lacs in Q4 FY25, while total expenses surged to ₹93.70 lacs from ₹17.45 lacs in the same period last year, primarily on account of higher other expenses of ₹83.39 lacs. The preceding quarter ended December 31, 2025 recorded a profit of ₹46.23 lacs on revenue of ₹54.19 lacs.

Metric: Q4 FY26 (Audited) Q3 FY26 (Unaudited) Q4 FY25 (Audited) Revenue from Operations: 57.82 54.19 135.23 Total Expenses: 93.70 7.96 17.45 Profit/(Loss) Before Tax: (35.88) 46.23 117.78 Net Profit/(Loss) After Tax: (35.88) 46.23 117.78

Balance Sheet and Capital Position

As at March 31, 2026, total assets stood at ₹9,939.89 lacs compared to ₹9,201.77 lacs as at March 31, 2025. Non-current assets increased to ₹9,891.19 lacs from ₹8,934.90 lacs, supported by growth in non-current investments to ₹3,278.23 lacs from ₹2,384.41 lacs and non-current loans at ₹6,612.97 lacs versus ₹6,550.50 lacs. Current assets declined to ₹48.70 lacs from ₹266.86 lacs, with cash and cash equivalents reducing to ₹32.16 lacs from ₹197.59 lacs.

On the equity and liabilities side, paid-up equity share capital increased to ₹9,026.03 lacs from ₹6,526.03 lacs, reflecting share issuances during the year. Other equity stood at ₹882.68 lacs as at March 31, 2026, compared to ₹2,666.74 lacs in the prior year. Total shareholders' funds were ₹9,908.71 lacs versus ₹9,192.77 lacs previously.

Balance Sheet Item: 31st March 2026 (₹ lacs) 31st March 2025 (₹ lacs) Non-Current Assets: 9,891.19 8,934.90 Current Assets: 48.70 266.86 Total Assets: 9,939.89 9,201.77 Equity Share Capital: 9,026.03 6,526.03 Other Equity: 882.68 2,666.74 Shareholders' Funds: 9,908.71 9,192.77 Non-Current Liabilities: 9.73 - Current Liabilities: 21.45 9.00 Total Equity and Liabilities: 9,939.89 9,201.77

Cash Flow Summary

The standalone statement of cash flows, prepared under the indirect method as per Ind AS-7, showed net cash flow from operating activities of ₹156.83 lacs for the year ended March 31, 2026, compared to ₹108.20 lacs in the prior year. Net cash used in investing activities was ₹956.29 lacs, against ₹3,261.86 lacs in FY25, primarily reflecting investments in shares and long-term loan advances. Cash flow from financing activities amounted to ₹630.00 lacs, driven by proceeds from issue of shares, compared to ₹3,570.00 lacs in FY25. The closing cash and cash equivalents balance stood at ₹32.16 lacs as against an opening balance of ₹201.63 lacs.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.